| Literature DB >> 26819651 |
Maureen Beederman1, Joseph D Lamplot1, Guoxin Nan2, Jinhua Wang3, Xing Liu2, Liangjun Yin3, Ruidong Li3, Wei Shui3, Hongyu Zhang3, Stephanie H Kim1, Wenwen Zhang3, Jiye Zhang3, Yuhan Kong3, Sahitya Denduluri1, Mary Rose Rogers1, Abdullah Pratt1, Rex C Haydon1, Hue H Luu1, Jovito Angeles1, Lewis L Shi1, Tong-Chuan He4.
Abstract
Bone morphogenetic proteins (BMPs) are members of the TGF-β superfamily and have diverse functions during development and organogenesis. BMPs play a major role in skeletal development and bone formation, and disruptions in BMP signaling cause a variety of skeletal and extraskeletal anomalies. Several knockout models have provided insight into the mechanisms responsible for these phenotypes. Proper bone formation requires the differentiation of osteoblasts from mesenchymal stem cell (MSC) precursors, a process mediated in part by BMP signaling. Multiple BMPs, including BMP2, BMP6, BMP7 and BMP9, promote osteoblastic differentiation of MSCs both in vitro and in vivo. BMP9 is one of the most osteogenic BMPs yet is a poorly characterized member of the BMP family. Several studies demonstrate that the mechanisms controlling BMP9-mediated osteogenesis differ from other osteogenic BMPs, but little is known about these specific mechanisms. Several pathways critical to BMP9-mediated osteogenesis are also important in the differentiation of other cell lineages, including adipocytes and chondrocytes. BMP9 has also demonstrated translational promise in spinal fusion and bone fracture repair. This review will summarize our current knowledge of BMP-mediated osteogenesis, with a focus on BMP9, by presenting recently completed work which may help us to further elucidate these pathways.Entities:
Keywords: BMP; BMP9; Bone Regeneration; IGF; MSCs; Mesenchymal Stem Cells; Osteogenesis; Signal Transduction; TGF-β; Wnt
Year: 2013 PMID: 26819651 PMCID: PMC4725591 DOI: 10.4236/jbise.2013.68A1004
Source DB: PubMed Journal: J Biomed Sci Eng ISSN: 1937-6871